| 摘要 |
<p>The present invention relates to the use of a cloned GABAA receptor subtype composed of the α2, β3 and η2 subunits for the identification of benzodiazepine receptor ligands with selective anxiolytic properties (i.e. non-sedative anxiolytica). Affinity and/or efficacy of the ligands are measured at different cloned GABAA receptor subtypes.</p> |
